Abstract Diagnostic karyotype provides the framework for risk-stratification schemes in acute myeloid leukemia (AML); however, the prognostic significance of many rare recurring cytogenetic abnormalities remains uncertain. We studied the outcomes of 5876 patients (16-59 years of age) who were classi...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!